These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34650220)

  • 21. Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy.
    Gerendas BS; Kroisamer JS; Buehl W; Rezar-Dreindl SM; Eibenberger KM; Pablik E; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2018 Nov; 96(7):e776-e782. PubMed ID: 29338130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central Serous Chorioretinopathy Analyzed by Multimodal Imaging.
    Han L; de Carvalho JRL; Parmann R; Tezel TH; Chang S; Sharma T; Sparrow JR
    Transl Vis Sci Technol; 2021 Jan; 10(1):15. PubMed ID: 33510954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.
    Fujita K; Yuzawa M; Mori R
    Retina; 2011 Apr; 31(4):772-8. PubMed ID: 20890236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT.
    Iacono P; Battaglia PM; Papayannis A; La Spina C; Varano M; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1889-97. PubMed ID: 25563727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Dijkman G; Peters PJH; Tsonaka R; MacLaren RE; Downes SM; Fauser S; Boon CJF; Hoyng CB
    Am J Ophthalmol; 2020 Aug; 216():80-89. PubMed ID: 32289294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy.
    Gulkas S; Sahin O
    Eur J Ophthalmol; 2020 Sep; 30(5):1053-1060. PubMed ID: 31256613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Early and Late Morphological and Functional Changes After Verteporfin Photodynamic Therapy.
    Iacono P; Tedeschi M; Boccassini B; Chiaravalloti A; Varano M; Parravano M
    Retina; 2019 May; 39(5):980-987. PubMed ID: 29346241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal Analysis of Retinal Thickness and Retinal Function in Eyes with Large Drusen Secondary to Intermediate Age-Related Macular Degeneration.
    Saßmannshausen M; Zhou J; Pfau M; Thiele S; Steinberg J; Fleckenstein M; Holz FG; Schmitz-Valckenberg S
    Ophthalmol Retina; 2021 Mar; 5(3):241-250. PubMed ID: 32721592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China.
    Zhao T; Li J; Wang Y; Guo X; Sun Y
    Ann Med; 2023 Dec; 55(1):2227424. PubMed ID: 37382371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting retinal sensitivity using optical coherence tomography parameters in central serous chorioretinopathy.
    Kanda S; Zhou HP; Inoue T; Fujino R; Sugiura A; Aoyama Y; Kadonosono K; Maruyama-Inoue M; Obata R; Asaoka R
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3499-3504. PubMed ID: 35665852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
    Song IS; Shin YU; Lee BR
    Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.
    Karakus SH; Basarir B; Pinarci EY; Kirandi EU; Demirok A
    Eye (Lond); 2013 May; 27(5):612-20. PubMed ID: 23519277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy.
    Battista M; Borrelli E; Parravano M; Gelormini F; Tedeschi M; De Geronimo D; Sacconi R; Querques L; Bandello F; Querques G
    Br J Ophthalmol; 2020 Oct; 104(10):1453-1457. PubMed ID: 31949095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical coherence tomography-based deep-learning model for detecting central serous chorioretinopathy.
    Yoon J; Han J; Park JI; Hwang JS; Han JM; Sohn J; Park KH; Hwang DD
    Sci Rep; 2020 Nov; 10(1):18852. PubMed ID: 33139813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Blanco-Garavito R; Souied EH; Keunen JEE; MacLaren RE; Querques G; Fauser S; Downes SM; Hoyng CB; Boon CJF
    Am J Ophthalmol; 2019 Sep; 205():1-10. PubMed ID: 30951686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy.
    Altınel MG; Acikalin B; Gunes H; Demir G
    Lasers Med Sci; 2021 Sep; 36(7):1505-1514. PubMed ID: 33409750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Grzybowski A
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2299-2306. PubMed ID: 28831603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photoreceptor layer map using spectral-domain optical coherence tomography.
    Lee JE; Lim DW; Bae HY; Park HJ
    Optom Vis Sci; 2009 Dec; 86(12):E1320-7. PubMed ID: 19844189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy.
    Iwase T; Yokouchi H; Kitahashi M; Kubota-Taniai M; Baba T; Yamamoto S
    Biomed Res Int; 2020; 2020():3190136. PubMed ID: 32908883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.